natgillin/translations-raw huggingface dataset:
• Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. 
• Nekaterim bolnikom z dolgotrajno sladkorno boleznijo tipa 2 in boleznijo srca ali predhodno možgansko kapjo, ki so prejemali pioglitazon in insulin, se je pojavilo srčno popuščanje.
Infusion systems at concentrations from 0.1 units/ml to 1.0 units/ml insulin lispro in 0.9% sodium chloride or 5% dextrose are stable at room temperature for 48 hours. 
Infuzijski sistemi s koncentracijami od 0,1 enote/ml do 1,0 enote/ml insulina lispro v 9 mg/ml (0,9 %) raztopini natrijevega klorida ali v 50 mg/ml (5 %) raztopini glukoze, so pri sobni temperaturi obstojni 48 ur.
Cases of oedema have been reported with insulin therapy, particularly if previous poor metabolic control is improved by intensified insulin therapy. 
Med zdravljenjem z insulinom so bili opisani primeri edemov, zlasti če se predhodno slaba presnovna urejenost z intenziviranim insulinskim zdravljenjem izboljša.
• A few people who have had hypoglycaemia after switching from animal insulin to human insulin have reported that the early warning symptoms were less obvious or different. 
• Malo bolnikov, ki so se jim po prehodu z živalskega na humani insulin pojavile hipoglikemije, so navajali, da so bili zgodnji opozorilni znaki manj očitni ali drugačni.
Always perform a safety test 
Vedno opravite varnostni preizkus.
Clean the skin as instructed. 
Kožo očistite v skladu z navodili.
Do not use it if it appears cloudy, thickened, or slightly coloured or if solid particles are visible. 
Ne uporabite je, če je motna, zgoščena ali rahlo obarvana ali če so v njej vidni trdni delci.
Insulin name 
Ime insulina
In in vitro tests, including binding to insulin receptor sites and effects on growing cells, insulin lispro behaved in a manner that closely resembled human insulin. 
V preiskavah in vitro, vključno z vezavo na insulinske receptorje in učinke na rastoče celice, se je insulin lispro vedel zelo podobno kot humani insulin.
Pack sizes: 1 or 5 vials. 
Velikosti pakiranj: 1 ali 5 vial.
No specific frequency for hypoglycaemia is presented, since hypoglycaemia is a result of both the insulin dose and other factors e.g. a patient`s level of diet and exercise. 
Pogostnost hipoglikemije ni specifično navedena, kajti hipoglikemija je posledica tako odmerka insulina kot drugih dejavnikov, na primer bolnikove prehrane in telesne dejavnosti.
• Inject under the skin, as you were taught. 
• Injicirajte pod kožo, kot so vas naučili.
Clinical trials have been performed in children (61 patients aged 2 to 11) and children and adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to human soluble insulin. 
Klinične študije, v katerih so primerjali insulin lispro s topnim humanim insulinom, so bile izvedene pri otrocih (61 bolnikov, starih od 2 do 11 let) in otrocih in mladostnikih (481 bolnikov, starih od 9 do 19 let).
• Your pen contains a total of 300 units of insulin. 
• Vaš peresnik vsebuje vsega skupaj 300 enot insulina.
Always carry a spare pen and spare needles in case they got lost or stop working. 
Vedno imejte pri sebi rezervni peresnik in rezervne igle za primer, da peresnik izgubite ali da neha delovati.
Manufacturer: Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany. 
Izdelovalec: Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Nemčija.
If you see air bubbles • You may see air bubbles in the insulin. 
Če opazite zračne mehurčke • V insulinu lahko opazite zračne mehurčke.
Leave the cartridge in the pen. 
Pustite vložek v peresniku.
Pull the needle out and apply gentle pressure over the injection site for several seconds. 
Izvlecite iglo in nekaj sekund rahlo pritiskajte na mesto injiciranja.
Oedema (e.g. swelling in arms, ankles; fluid retention) has been reported, particularly at the start of insulin therapy or during a change in therapy to improve control of your blood glucose. 
Poročali so o edemih (npr. otekanju rok, gležnjev, zastajanju tekočine), zlasti na začetku zdravljenja z insulinom ali pri spremembi zdravljenja zaradi izboljšanja nadzora sladkorja v krvi.
Now inject air into the Insulin lispro Sanofi vial in the same manner, but do not withdraw the needle. 
Zdaj injicirajte zrak v vialo zdravila Insulin lispro Sanofi na enak način, vendar ne izvlecite igle.
Insulin requirements and dosage adjustment Insulin requirements may be increased during illness or emotional disturbances. 
Potrebe po insulinu in prilagoditev odmerjanja Potreba po insulinu se lahko poveča med boleznijo ali v primeru čustvenih obremenitev.
Hypersensitivity to insulin lispro or to any of the excipients listed in section 6.1. 
Preobčutljivost za insulin lispro ali katero koli pomožno snov, navedeno v poglavju 6.1.
It is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy. 
Med celotno nosečnostjo je pri bolnicah, ki se zdravijo z insulinom (imajo gestacijsko sladkorno bolezen ali sladkorno bolezen, odvisno od insulina) nujno vzdrževanje dobre urejenosti sladkorne bolezni.
20 units selected Odd numbers are shown as a line between even numbers: 
Liha števila so prikazana kot črtice med sodimi števili:
The use of dosages which are inadequate or discontinuation of treatment, especially in insulin-dependent diabetics, may lead to hyperglycaemia and diabetic ketoacidosis; conditions which are potentially lethal. 
Uporaba nezadostnih odmerkov ali prenehanje zdravljenja lahko zlasti pri sladkornih bolnikih, ki so odvisni od insulina, povzroči hiperglikemijo in diabetično ketoacidozo; obe sta lahko smrtni.
Insulin lispro Sanofi solution for injection should be given by subcutaneous injection or by continuous subcutaneous infusion pump (see section 4.2) and may, although not recommended, also be given by intramuscular injection. 
Zdravilo Insulin lispro Sanofi raztopino za injiciranje je treba injicirati subkutano ali dajati s kontinuirano subkutano infuzijsko črpalko (glejte poglavje 4.2); injicirati ga je mogoče tudi intramuskularno, vendar pa to ni priporočljivo.
Within muscle tissue this includes increasing glycogen, fatty acid, glycerol and protein synthesis and amino acid uptake, while decreasing glycogenolysis, gluconeogenesis, ketogenesis, lipolysis, protein catabolism and amino acid output. 
V mišičnem tkivu to vključuje povečanje sinteze glikogena, maščobnih kislin, glicerola in beljakovin, ter privzema aminokislin, ob hkratnem zmanjšanju glikogenolize, glukoneogeneze, ketogeneze, lipolize, razgradnje beljakovin in sproščanja aminokislin.
Insulin in vials must not be mixed with insulin in cartridges. 
Insulina v vialah se ne sme mešati z insulinom v vložkih.
Eat glucose or sugar after the glucagon injection. 
Po injekciji glukagona pojejte nekaj glukoze ali sladkorja.
• Keep new pens in a fridge, at 2°C to 8°C. 
• Nove peresnike shranjujte v hladilniku pri temperaturi od 2 do 8°C.
• If you turn past your dose, you can turn back down. 
• Če zavrtite mimo svojega odmerka, lahko izbirnik zavrtite nazaj.
Studies also demonstrate that the dissociation of binding to the insulin receptor of insulin lispro is equivalent to human insulin. 
Študije so tudi pokazale, da je disociacija insulina lispro iz vezave na insulinski receptor enaka kot pri humanem insulinu.
This usually clears up in anything from a few days to a few weeks. 
To po navadi mine v nekaj dneh do nekaj tednih.
B Throw away the used needle in a puncture resistant container, or as told by your pharmacist or local authority. 
B Uporabljene igle zavrzite v vsebnik, odporen proti prebadanju, ali kot vam naroči farmacevt ali pristojni lokalni organ.
Correction of moderately severe hypoglycaemia can be accomplished by intramuscular or subcutaneous administration of glucagon, followed by oral carbohydrate when the patient recovers sufficiently. 
Zmerno hudo hipoglikemijo je mogoče odpraviti z intramuskularnim ali subkutanim injiciranjem glukagona; temu mora slediti zaužitje ogljikovih hidratov, ko si bolnik dovolj opomore.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 
Če imate o uporabi tega zdravila dodatna vprašanja, se posvetujte z zdravnikom ali farmacevtom.
Stabilise the skin by spreading it or pinching up a large area. 
Učvrstite kožo z raztezanjem ali pa večje področje kože stisnite v kožno gubo.
As with all insulin preparations, the time course of insulin lispro action may vary in different individuals or at different times in the same individual and is dependent on dose, site of injection, blood supply, temperature and physical activity. 
Kakor velja za vse insuline, se lahko časovni potek delovanja insulina razlikuje tako med posamezniki kot pri vsakem posamezniku v različnih časovnih obdobjih ter je odvisen od odmerka, mesta injiciranja, prekrvitve tkiva, temperature in telesne dejavnosti.
• Do not press at an angle - your thumb could block the dose selector from turning. 
• Ne pritiskajte pod kotom, ker lahko s palcem onemogočite vrtenje izbirnika odmerka.
• Inject Insulin lispro Sanofi under the skin (subcutaneous use or “SC”). 
• Zdravilo Insulin lispro Sanofi injicirajte pod kožo (subkutana uporaba ali "s.c.").
• Do not drop your pen or knock it against hard surfaces. 
• Pazite, da vam peresnik kam ne pade in da z njim ne udarite ob trde površine.
If you think you are having this sort of insulin allergy with Insulin lispro Sanofi, tell your doctor at once. 
Če menite, da imate takšno alergijo na insulin z zdravilom Insulin lispro Sanofi, o tem nemudoma obvestite zdravnika.
Fertility Insulin lispro did not induce fertility impairment in animal studies (see section 5.3). 
Plodnost V študijah na živalih insulin lispro ni zmanjšal plodnosti (glejte poglavje 5.3).
Hyperglycaemia can be brought about by: 
Vzroki za hiperglikemijo so lahko:
This should be kept in mind, if treatment with the combination of pioglitazone and Insulin lispro Sanofi is considered. 
To je treba upoštevati pri načrtovanju zdravljenja s kombinacijo pioglitazona in zdravila Insulin lispro Sanofi.
Insulin lispro Sanofi is also indicated for the initial stabilisation of diabetes mellitus. 
Zdravilo Insulin lispro Sanofi je indicirano tudi za začetno stabilizacijo sladkorne bolezni.
• In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. 
• V primeru hipoglikemije je treba infundiranje ustaviti, dokler hipoglikemija ne mine.
A consequence of the pharmacodynamics of rapid-acting insulin analogues is that if hypoglycaemia occurs, it may occur earlier after an injection when compared with soluble human insulin. 
Posledica farmakodinamike hitrodelujočih analogov insulina je, da v primeru pojava hipoglikemije ta lahko nastopi hitreje po injiciranju kakor pri topnem humanem insulinu.
Combination of Insulin lispro Sanofi with pioglitazone Cases of cardiac failure have been reported when pioglitazone was used in combination with insulin, especially in patients with risk factors for development of cardiac heart failure. 
Kombinacija zdravila Insulin lispro Sanofi s pioglitazonom Poročali so o primerih srčnega popuščanja med uporabo pioglitazona v kombinaciji z insulinom, zlasti pri bolnikih z dejavniki tveganja za srčno popuščanje.
Solution for injection 1 x 10 ml 
raztopina za injiciranje 1 x 10 ml
• A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels. 
• Napaka v delovanju črpalke ali zamašitev infuzijskega sistema lahko povzročita hitro zvišanje koncentracije glukoze v krvi.
Insulin requirements may be reduced in the presence of medicinal products with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors, selective serotonin reuptake inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol. 
Potrebo po insulinu lahko zmanjšajo zdravila s hipoglikemičnim delovanjem, na primer peroralni antidiabetiki, salicilati (na primer acetilsalicilna kislina), sulfonamidi, nekateri antidepresivi (zaviralci monoaminooksidaze, selektivni zaviralci prevzema serotonina), nekateri zaviralci angiotenzinske konvertaze (kaptopril, enalapril), antagonisti angiotenzina II, antagonisti adrenergičnih receptorjev beta, oktreotid ali alkohol.
Dose selector Injection button 
Izbirnik odmerka Gumb za injiciranje
The number of units is shown in the dose window of the pen regardless of strength and no dose conversion should be done when transferring a patient to a new strength or to another insulin lispro pre-filled pen with a different dose step. 
Število enot je prikazano v odmernem okencu na injekcijskem peresniku ne glede na jakost, zato ob prehodu bolnika na novo jakost ali na drug z insulinom lispro napolnjeni injekcijski peresnik z drugačnim korakom odmerjanja, preračunavanje odmerka ni potrebno.
sanofi-aventis groupe 54 rue La Boétie F - 75008 Paris France 
sanofi-aventis groupe 54 rue La Boétie F - 75008 Paris Francija
D Pull off the inner needle cap and throw away. 
D Snemite notranji pokrovček igle in ga zavrzite.
If this happens to you, tell your doctor. 
Če opazite takšno reakcijo, povejte zdravniku.
Conditions which may make the early warning symptoms of hypoglycaemia different or less pronounced include long duration of diabetes, intensified insulin therapy, diabetic nerve disease or medications such as beta-blockers. 
Stanja, pri katerih so zgodnji opozorilni znaki hipoglikemije drugačni ali manj izraziti, so dolgotrajna sladkorna bolezen, intenzivirano insulinsko zdravljenje, diabetična nevropatija ali zdravila, kakršna so antagonisti adrenergičnih receptorjev beta.
B Pull off the pen cap. 
B Snemite pokrovček peresnika.
B Keep the needle straight and screw it onto the pen until fixed. 
B Iglo držite naravnost in jo privijte na peresnik, tako da je povsem fiksirana.
Do not store the vial in a refrigerator. 
Viale ne shranjujte v hladilniku.
A glucagon injection can treat quite severe hypoglycaemia. 
Z injekcijo glukagona je mogoče odpraviti tudi hujšo hipoglikemijo.
STEP 6: Remove the needle 
KORAK: Odstranite iglo
It doesn't matter which injection site you use, either upper arm, thigh, buttock or abdomen, your Insulin lispro Sanofi injection will still work quicker than soluble human insulin. 
Ne glede na to, katero mesto injiciranja uporabite - nadlaket, stegno, zadnjico ali trebuh - bo zdravilo Insulin lispro Sanofi delovalo hitreje kot navadni humani insulin.
As with all insulin preparations, the duration of action of Insulin lispro Sanofi is dependent on dose, site of injection, blood supply, temperature, and physical activity. 
Kakor velja za vse insuline, je trajanje delovanja zdravila Insulin lispro Sanofi odvisno od odmerka, mesta injiciranja, prekrvitve tkiva, temperature in telesne dejavnosti.
If mixing insulins, see section “Mixing Insulin lispro Sanofi with longer-acting human insulins” below and section 6.2. 
Če mešate insuline, glejte poglavje "Mešanje zdravila Insulin lispro Sanofi s humanimi insulini z dolgotrajnejšim delovanjem", spodaj, in poglavje 6.2. 1.
Before using the pre-filled pen, the user manual included in the package leaflet must be read carefully. 
Pred uporabo napolnjenega injekcijskega peresnika je treba natančno prebrati navodila za uporabo, navedena na priloženem navodilu.
Common problems of diabetes 
Pogoste težave pri sladkorni bolezni
Avoidance of medication errors when using Insulin lispro Sanofi Patients must be instructed to always check the insulin label before each injection to avoid accidental mix-ups between Insulin lispro Sanofi and other insulin products. 
Izogibanje napakam pri uporabi zdravila Insulin lispro Sanofi Bolnikom je treba naročiti, naj pred vsakim injiciranjem preverijo nalepko insulina, da bi se izognili naključnim zamenjavam zdravila Insulin lispro Sanofi in drugih insulinov.
Glucodynamic differences between insulin lispro and soluble human insulin, as measured during a glucose clamp procedure, were maintained over a wide range of renal function. 
Razlika v glukodinamiki med insulinom lispro in topnim humanim insulinom, merjeni s postopkom glukozne vklenjenosti ("clamp"), se je ohranjala v širokem razponu delovanja ledvic.
• Every time you use a pre-filled pen you must use a new needle. 
• Ob vsaki uporabi napolnjenega injekcijskega peresnika morate uporabiti novo iglo.
You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood. 
Sladkorna bolezen se pojavi, če trebušna slinavka ne izloča dovolj insulina za uravnavanje koncentracije glukoze v krvi.
The infusion set (tubing and cannula) should be changed in accordance with the instructions in the product information supplied with the infusion set. 
Infuzijski komplet (cevko in kanilo) je treba menjati v skladu z navodili, priloženimi infuzijskemu kompletu.
Never re-use needles. 
Igel nikoli ne uporabljajte ponovno.
Do not use the medicinal product if it appears cloudy, thickened, or slightly coloured or if solid particles are visible. 
Tega zdravila ne uporabite, če je motno, zgoščeno ali rahlo obarvano ali če so v njem vidni trdni delci.
• Use a clean, sterile syringe and needle to pierce the rubber stopper and draw in the amount of Insulin lispro Sanofi you want. 
• Uporabite čisto, sterilno brizgo in iglo, da boste prebodli gumijast zamašek in potegnili želeno količino zdravila Insulin lispro Sanofi.
Insulin lispro Sanofi cartridges are to be used with JuniorSTAR, Tactipen, AllStar or AllStar PRO pens as recommended in the user manual (see section 4.2 and 4.4). 
Vložke zdravila Insulin lispro Sanofi je treba uporabljati z injekcijskimi peresniki JuniorSTAR, Tactipen, AllStar ali AllStar PRO, kot je priporočeno v navodilu za uporabo (glejte poglavji 4.2 in
Marketing Authorisation Holder: sanofi-aventis groupe, 54 rue La Boétie, F - 75008 Paris, France 
Imetnik dovoljenja za promet z zdravilom: sanofi-aventis groupe, 54 rue La Boétie, F - 75008 Paris, Francija
Insulin lispro did not induce fertility impairment, embryotoxicity or teratogenicity in animal studies. 
Insulin lispro v študijah na živalih ni zmanjšal plodnosti, ni bil embriotoksičen in ni bil teratogen.
Do not overtighten. 
Ne privijte je preveč.
Rubber seal 
Gumijasta zapora
It is recommended that health care professionals record the brand name (“Insulin lispro Sanofi”) and Lot number (included on the outer cartons and labels of each vial, cartridge and pre-filled pen) and provide this information when reporting any side effects. 
Priporočljivo je, da zdravniki zabeležijo zaščiteno ime zdravila ("Insulin lispro Sanofi") in številko serije (navedena je na zunanji ovojnini in nalepki vsake viale, vložka in napolnjenega injekcijskega peresnika) ter ta podatka posredujejo, kadar poročajo o kakršnem koli neželenem učinku.
Hold the vial and syringe firmly in one hand and shake gently. 
Vialo in injekcijsko brizgo trdno držite v eni roki in jo narahlo stresite.
You should never mix Insulin lispro Sanofi with insulins produced by other manufacturers or animal insulins. 
Zdravila Insulin lispro Sanofi ne smete nikoli mešati z insulini drugih izdelovalcev ali z živalskimi insulini.
Hypoglycaemia or hyperglycaemia 
Hipoglikemija ali hiperglikemija
Mixing Insulin lispro Sanofi with longer-acting human insulins (see section 6.2) 
Mešanje zdravila Insulin lispro Sanofi s humanimi insulini z dolgotrajnejšim delovanjem (glejte poglavje 6.2)
• reduced or absent warning signs of hypoglycaemia 
• zmanjšanje opozorilne znake hipoglikemije ali jih sploh nimate.
• The other ingredients are: metacresol, glycerol, disodium hydrogen phosphate heptahydrate, zinc oxide and water for injection. 
• Druge sestavine so: metakrezol, glicerol, dinatrijev hidrogenfosfat heptahidrat, cinkov oksid in voda za injekcije.
• Never store your pen with the needle attached. 
• Nikoli ne shranite peresnika z nameščeno iglo.
In the event of a hypoglycaemic episode, the infusion should be stopped until the episode is resolved. 
V primeru hipoglikemije je treba infundiranje ustaviti, dokler hipoglikemija ne mine.
Detailed information is available on the website of the European Medicines Agency http://www.ema.europa.eu 
Podrobne informacije so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu
• thyroid hormone replacement therapy, 
• nadomestno zdravljenje s ščitničnimi hormoni,
• Always perform a safety test before each injection. 
• Pred vsakim injiciranjem vedno opravite varnostni preizkus.
Inject Insulin lispro Sanofi as your physician or nurse has taught you. 
Zdravilo Insulin lispro Sanofi injicirajte, kot vas je naučil zdravnik ali medicinska sestra.
Withdraw the needle and lay the syringe down so that the needle does not touch anything. 
Izvlecite iglo in injekcijsko brizgo odložite tako, da se igla ničesar ne dotika.
After first use: 
Po prvi uporabi:
Remove the needle from the vial and lay the syringe down so that the needle does not touch anything. 
Izvlecite iglo iz viale in injekcijsko brizgo odložite tako, da se igla ničesar ne dotika.
If you do you might not get your dose (underdosing) or get too much (overdosing) as the needle could block. 
Če iglo uporabite ponovno, se lahko zgodi, da ne boste dobili pravega odmerka (premajhno odmerjanje), ali boste dobili prevelik odmerek (preveliko odmerjanje), ker se igla lahko zamaši.
Patients should be advised to take precautions to avoid hypoglycaemia whilst driving, this is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia. 
To je še posebno pomembno pri bolnikih, ki se manj ali sploh ne zavedajo opozorilnih znakov hipoglikemije ali imajo pogoste hipoglikemije.
• You can see roughly how many units of insulin are left by looking at where the plunger is on the insulin scale. 
• Koliko enot insulina je še preostalo, lahko približno ocenite tako, da pogledate, kjer ob merilu insulina je bat.
Mild hypoglycaemic episodes will respond to oral administration of glucose or other sugar or saccharated products. 
Blage hipoglikemije se odzovejo na zaužitje glukoze ali kakšnega drugega sladkorja ali sladkanih živil.
This rapid onset of activity allows an Insulin lispro Sanofi injection (or, in the case of administration by continuous subcutaneous infusion, an Insulin lispro Sanofi bolus) to be given very close to mealtime. 
Ta hitri začetek delovanja omogoča, da je mogoče zdravilo Insulin lispro Sanofi (ali bolus zdravila Insulin lispro Sanofi v primeru uporabe z neprekinjeno subkutano infuzijo) dati časovno zelo blizu obroka.
Insert the needle and inject as instructed. 
Zabodite iglo v kožo in injicirajte v skladu z navodili.
Insulin lispro Sanofi 100 units/ml solution for injection in vial This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. 
Insulin lispro Sanofi 100 enot/ml raztopina za injiciranje v viali Zdravila se ne sme mešati z drugimi zdravili razen s tistimi, ki so navedena v poglavju 6.6. 6.3 Rok uporabnosti
Before removing the needle from the vial, check the syringe for air bubbles that reduce the amount of Insulin lispro Sanofi in it. 
Preden izvlečete iglo iz viale, preverite, ali so v injekcijski brizgi zračni mehurčki, ki zmanjšajo količino zdravila Insulin lispro Sanofi v njej.
Always do a safety test before each injection - this is to: 
Pred vsakim injiciranjem opravite varnostni preizkus, da boste:
Injecting a dose 
Injiciranje odmerka
Keep your Insulin lispro Sanofi pre-filled pen in use at room temperature (below 30°C) and dispose of after 4 weeks. 
Napolnjeni injekcijski peresnik z zdravilom Insulin lispro Sanofi shranjujte na sobni temperaturi (do 30°C) in ga zavrzite po 4 tednih.
Solution for injection 5 x 3 ml 
raztopina za injiciranje 5 x 3 ml
Insulin lispro Sanofi is suitable for use in adults and children. 
Zdravilo Insulin lispro Sanofi je primerno za odrasle in za otroke.
The primary activity of insulin lispro is the regulation of glucose metabolism. 
Primarno delovanje insulina lispro je uravnavanje presnove glukoze.